Literature DB >> 3262680

Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals.

M G Tovey1, J Content, I Gresser, J Gugenheim, B Blanchard, J Guymarho, P Poupart, M Gigou, A Shaw, W Fiers.   

Abstract

The gene of a cytokine designated IFN-beta-2, or IL-6, and recently identified as identical to the B cell-stimulatory factor 2, is transcribed at high levels in the spleen, liver, kidney, and peripheral blood leukocytes of normal individuals. The number of IFN-beta-2/IL-6 transcripts present endogenously in normal human tissues (0.6 to 16 copies/cell) is comparable to that present in normal cells induced in vitro with human rTNF. This is in marked contrast to the absence of detectable IFN-beta-1 transcripts (less than 0.0003 copy/cell) in the same samples of human tissue. The expression of the IFN-beta-2/IL-6 gene is closely associated with that of two other cytokines TNF, and IL-1. Thus, significant levels of IFN-beta-2/IL-6, TNF, IL-1 alpha, and IL-1 beta, mRNA were detected in all the samples of normal tissue tested and those samples which contained high levels of IFN-beta/IL-6 mRNA also contained high levels of TNF, and IL-1 beta mRNA. These results suggest that these cytokines may function in consort as regulators of cellular growth and function in normal tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262680

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Effect of cryopreservation on the properties of human endometrial stromal cells used in embryo co-culture systems.

Authors:  Ivan Bochev; Kalina Belemezova; Atanas Shterev; Stanimir Kyurkchiev
Journal:  J Assist Reprod Genet       Date:  2016-01-12       Impact factor: 3.412

2.  Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues.

Authors:  L P Ruco; A Stoppacciaro; D Pomponi; D Boraschi; A Santoni; A Tagliabue; S Uccini; C D Baroni
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

3.  Tissue-specific positive feedback requirements for production of type I interferon following virus infection.

Authors:  Arun Prakash; Eric Smith; Chien-Kuo Lee; David E Levy
Journal:  J Biol Chem       Date:  2005-03-14       Impact factor: 5.157

4.  Constitutive synthesis of tumor necrosis factor in the thymus.

Authors:  B P Giroir; T Brown; B Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 5.  Host defense against infections and inflammations: role of the multifunctional IL-6/IFN-beta 2 cytokine.

Authors:  M Revel
Journal:  Experientia       Date:  1989-06-15

6.  Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

7.  Genomic footprinting: detection of putative regulatory proteins in the promoter region of the interferon alpha-1 gene in normal human tissues.

Authors:  M Palmieri; M G Tovey
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

8.  The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.

Authors:  B P Giroir; J H Johnson; T Brown; G L Allen; B Beutler
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Autoregulation by eicosanoids of human Kupffer cell secretory products. A study of interleukin-1, interleukin-6, tumor necrosis factor-alpha, transforming growth factor-beta, and nitric oxide.

Authors:  C R Roland; J A Goss; M J Mangino; D Hafenrichter; M W Flye
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

10.  Constitutive nuclear NF-kappa B in cells of the monocyte lineage.

Authors:  M Frankenberger; A Pforte; T Sternsdorf; B Passlick; P A Baeuerle; H W Ziegler-Heitbrock
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.